Phase I/II Trial of S-1 plus paclitaxel combination chemotherapy in elderly patients with non-small lung cancer
Not Applicable
Suspended
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000003782
- Lead Sponsor
- Kyoto prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with serious complication 2)Patients with active double cancer 3)Patients with previous serious drug hyperseneitivity 4)receiving Flucytosine 5)Patients with alcohol allergy 6)Other conditions inadequate for this research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Phase I maximum tolerated dose, recommended dose Phase II response rate
- Secondary Outcome Measures
Name Time Method Phase I toxicity, response rate Phase II toxicity, disease control rate, overall survival, relation to biomarker